Thiazolidinediones, peroxisome proliferator-activated receptor γ agonists, regulate endothelial cell growth and secretion of vasoactive peptides
- 30 September 2001
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 158 (1) , 113-119
- https://doi.org/10.1016/s0021-9150(01)00430-0
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- PPARγ Agonists Enhance Human Vascular Endothelial Adhesiveness by Increasing ICAM-1 ExpressionBiochemical and Biophysical Research Communications, 1999
- Thiazolidinediones Down-Regulate Plasminogen Activator Inhibitor Type 1 Expression in Human Vascular Endothelial Cells: A Possible Role for PPARγ in Endothelial FunctionBiochemical and Biophysical Research Communications, 1999
- Peroxisome Proliferator-activated Receptor γ Ligands Are Potent Inhibitors of Angiogenesis in Vitro and in VivoJournal of Biological Chemistry, 1999
- PPARγ Activation in Human Endothelial Cells Increases Plasminogen Activator Inhibitor Type-1 ExpressionArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Thiazolidinediones Suppress Endothelin-1 Secretion from Bovine Vascular Endothelial Cells: A New Possible Role of PPARγ on Vascular Endothelial FunctionBiochemical and Biophysical Research Communications, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect.Journal of Clinical Investigation, 1995
- Vascular natriuretic peptideThe Lancet, 1992
- Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system".Journal of Clinical Investigation, 1992
- Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.Journal of Clinical Investigation, 1990